A study of antibody level in fully vaccinated individuals with covishield.
Not Applicable
- Registration Number
- CTRI/2021/06/034222
- Lead Sponsor
- Dr Hemangi Virani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who have taken two doses of covishield vaccine and willing to participate in the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method antibody titreTimepoint: 1, 3, 6 and 9 months
- Secondary Outcome Measures
Name Time Method To compare antibody titre between previously infected and non-infected personsTimepoint: 1, 3, 6 and 9 months